RATIONALE: Drugs used in chemotherapy such as alanosine use different ways to stop tumor
cells from dividing so they stop growing or die.
PURPOSE: This phase II trial is studying how well alanosine works in treating patients with
soft tissue sarcoma, sarcoma of the bone, mesothelioma, non-small cell lung cancer, or
pancreatic cancer.